Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
17 déc. 2024 08h30 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
13 déc. 2024 08h00 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
12 déc. 2024 08h00 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Third Quarter 2024 Financial Results
11 nov. 2024 16h02 HE
|
Assertio Holdings, Inc.
Third Quarter Total Net Product Sales of $28.7 Million Rolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 Million LAKE FOREST, Ill., Nov. 11, 2024 ...
Assertio Provides Response to Letter from Short-seller
11 nov. 2024 07h30 HE
|
Assertio Holdings, Inc.
Claims about Rolvedon and Assertio’s Accounting Practices are False and Baseless Short-seller’s Press Release is Another Improper Attempt to Enrich Himself at Assertio’s Expense Company Considering...
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
30 oct. 2024 08h00 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
11 oct. 2024 08h00 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04 oct. 2024 16h05 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
03 sept. 2024 16h05 HE
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Assertio Reports Second Quarter 2024 Financial Results
07 août 2024 16h01 HE
|
Assertio Holdings, Inc.
Assertio Reports Second Quarter 2024 Financial Results